[ Price : $8.95]
FDA clears a HeartFlow 510(k) for the HeartFlow Planner, a real-time virtual modeling tool for coronary artery disease interventio...[ Price : $8.95]
Federal Register notice: FDA announces an 11/14 Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss an Amarin...[ Price : $8.95]
Bloomberg Businessweek takes a lengthy review of the FDA involvement in the case of contaminated valsartan and other hypertension ...[ Price : $8.95]
A CNN opinion column calls for patent reform as a means of helping to address high drug prices.[ Price : $8.95]
FDA classifies as Class 1 an Allergan July recall of its Biocell textured breast implant products.[ Price : $8.95]
FDA asks the Allergenic Products Advisory Committee to comment on whether efficacy and safety data support approval of Aimmune The...[ Price : $8.95]
Federal Register notice: FDA determines that Sanofi Aventis Calcimar (calcitonin salmon) injection, 200 IU/mL was not withdrawn fr...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Tsunami MedTechs Aegea Vapo...